Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

NCT04632342 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiation Pneumonitis
Lung Cancer

Interventions

DRUG: HL301 tablet 300mg
DRUG: Placebo of HL301 tablet

Sponsor

Hanlim Pharm. Co., Ltd.